During this activity, fellows will review CGM reports and consider treatment recommendations. Upon completing this education activity, learners will be able to: 

Reviewed and updated by the following members of the Fellows Training Series Workgroup: 

Matthew Freeby, MD 
UCLA Medical Center 

Nauman Arif Jadoon, MBBS, MRCP, MAcadMed, FRSPH, FHEA 
NHS Greater Glasgow and Clyde, UK 

Hugo Torres, MD 
UCLA Medical Center 

 
STATEMENT OF INDEPENDENCE 

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force. 

DISCLOSURE POLICY 

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.  

The following faculty reported financial relationships: Matthew Freeby, MD: Receives clinical research grant funding from Novo Nordisk and Abbott Diabetes.  

The following faculty reported no relevant financial relationship: M. Nauman Arif Jadoon, MBBS, MRCP, MAcadMed, FRSPH, FHEA; Hugo Torres, MD 

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships. 

The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.